FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely oncology and can be used in treatment of tumours. The method involves introduction of an autologous vaccine representing heat-shock proteins recovered from tumour tissue of the patient in a complex with tumour antigens. Thus treatment with the autologous vaccine is preceded with introduction of an oncolytic attenuated Newcastle disease virus as an adjuvant.
EFFECT: application of the invention allows improving clinical effectiveness in tumours ensured by formation of a vaccine-induced specific immune response against tumour and additional stimulation of nonspecific immunity combined with cytolytic activity of the adjuvant.
2 cl, 4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF ONCOLOGY DISEASES | 2004 |
|
RU2271831C1 |
| METHOD FOR PREVENTION OF ONCOLOGICAL DISEASES | 2011 |
|
RU2500392C2 |
| METHOD FOR OBTAINING PREPARATION THAT CONTAINS THE COMPLEX OF HEAT SHOCK PROTEINS 70, 90, 96 ASSOCIATED WITH ANTIGENOUS PEPTIDES | 2005 |
|
RU2287339C1 |
| METHOD FOR BIOLOGICAL MATERIAL OBTAINING FOR CREATION OF AUTOLOGICAL ANTITUMOUR VACCINES | 2016 |
|
RU2640017C1 |
| METHOD OF TREATING METASTATIC CANCER USING SENDAI VIRUS | 2017 |
|
RU2662916C1 |
| METHOD FOR STIMULATING PRESENTING ACTIVITY OF DENDRITIC CELLS | 2019 |
|
RU2728592C1 |
| METHOD OF THERAPY OF MALIGNANT DISEASES | 2013 |
|
RU2597414C2 |
| VACCINE COMPOSITIONS, METHODS FOR APPLICATION THEREOF IN MELANOMA PREVENTION AND TREATMENT, AND GENETIC CONSTRUCTIONS FOR OBTAINING ACTIVE SUBSTANCES OF COMPOSITION | 2006 |
|
RU2333767C2 |
| MUCOSAL VACCINE FOR IMMUNE THERAPY OF DISEASES CAUSED BY HUMAN PAPILLOMA VIRUSES, AND RELATED THERAPY (VERSIONS) | 2008 |
|
RU2377305C1 |
| NEWCASTLE DISEASE NDVH-2 VIRUS STRAIN FOR STUDY OF POSSIBILITY OF VIRAL ONCOLYTIC PREPARATION DEVELOPMENT ON ITS BASIS | 2016 |
|
RU2644676C1 |
